Evidence map›Paper›PMID 30852489›Full record

ArticleBMJ evidence-based medicine2020

Cochrane vertebroplasty review misrepresented evidence for vertebroplasty with early intervention in severely affected patients.

William Clark, Paul Bird, Terrence Diamond, Peter Gonski, Val Gebski

Open access · hybridAbstract read
In one paragraph

Article in BMJ evidence-based medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Early vertebroplasty within 3 weeks of fracture for acute painful vertebral osteoporotic fractures: subgroup analysis of the VAPOUR trial and review of the literature.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2020
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

William ClarkDepartment of Interventional Radiology, St George Private Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-2352-9340
Paul BirdDepartment of Medicine, St George and Sutherland Clinical school, Univsersity of New South Wales, Kogarah, New South Wales, Australia.
Terrence DiamondDepartment of Medicine, St George and Sutherland Clinical school, Univsersity of New South Wales, Kogarah, New South Wales, Australia.
Peter GonskiDepartment of Aged Care, School of Public Health and Community Medicine, University of New South Wales, Randwick Campus, Randwick, New South Wales, Australia.
Val GebskiDepartment of Biostatistics, Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
Sutherland Hospital · AUSt George Hospital · AUThe University of Sydney · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Cochrane vertebroplasty review of April 2018 was replaced with an updated version in November 2018 to address complaints of errors in analysis. The updated version continues to misrepresent the evidence supporting early intervention with vertebroplasty for patients with uncontrolled, severe pain and fracture duration <6 weeks. The VAPOUR trial is the only blinded trial of vertebroplasty restricted to this patient group. It showed the benefit of vertebroplasty over placebo, particularly when the intervention occurred within 3 weeks of fracture. The Cochrane vertebroplasty review has ignored the positive outcomes in the VAPOUR trial. Open randomised trials of fractures <6-week duration support the positive findings of the VAPOUR trial. This is not described in the Cochrane review. The VAPOUR trial is clinically heterogeneous from other blinded trials. Cochrane protocol stipulates that clinically heterogeneous trials be described separately, as independent evidence, and not combined in analysis with dissimilar trials. Failure to observe this represents a serious protocol breach in the Cochrane review.

Indexed as

Evidence-Based MedicineVertebroplastyBack PainConflict of InterestFractures, CompressionHumansOsteoporotic FracturesPublication BiasResearch DesignSpinal FracturesSystematic Reviews as TopicTime-to-Treatmentback paingeriatric medicineinterventional radiologyneurosurgeryrheumatology

Identifiers

PMID30852489
PMCPMC7286037
OpenAlexW2922402877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.